{"disease":{"id":"oligoprogressive","name":"oligoprogressive"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06367972","title":"A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06101277","title":"Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT06103669","title":"Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)","phase":"NA","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT06585007","title":"Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":246,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT06918951","title":"Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers","phase":"NA","overall_status":"RECRUITING","enrollment_count":194,"lead_sponsor_name":"British Columbia Cancer Agency","has_results":false},{"nct_id":"NCT06101290","title":"Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT06841172","title":"Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":132,"lead_sponsor_name":"Shandong Cancer Hospital and Institute","has_results":false},{"nct_id":"NCT05301881","title":"COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":118,"lead_sponsor_name":"The Netherlands Cancer Institute","has_results":false},{"nct_id":"NCT06103682","title":"LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT07076693","title":"Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":97,"lead_sponsor_name":"Shanghai Chest Hospital","has_results":false},{"nct_id":"NCT04970693","title":"A Study of Furmonertinib Combined With Radiotherapy for Non-small Cell Lung Cancer With Oligoprogression","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":64,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06813664","title":"ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT07112170","title":"Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":52,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT06925984","title":"Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)","phase":"NA","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Jules Bordet Institute","has_results":false},{"nct_id":"NCT04989725","title":"Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":46,"lead_sponsor_name":"Centre hospitalier de l'Université de Montréal (CHUM)","has_results":false},{"nct_id":"NCT07038304","title":"The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":35,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT04974671","title":"Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT04838899","title":"Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Sunnybrook Health Sciences Centre","has_results":false},{"nct_id":"NCT03696277","title":"SAbR For Oligo-Progressive Renal Cell Cancer.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false},{"nct_id":"NCT05846659","title":"Study of PULSAR-ICI +/- IMSA101 in Patients with Oligoprogressive Solid Tumor Malignancies","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":16,"lead_sponsor_name":"ImmuneSensor Therapeutics Inc.","has_results":false},{"nct_id":"NCT04485026","title":"Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false}],"total":21},"guidelines":[],"source":"Drug Landscape verified database"}